These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23909592)

  • 41. [Outcomes of in vitro fertilization-embryo transfer and intracytoplasmic sperm injection for non-male infertility patients with a low number of oocytes retrieved].
    Tan H; Chen L; He L; Quan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):251-4. PubMed ID: 22381770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.
    Baerwald A; Anderson P; Yuzpe A; Case A; Fluker M
    Fertil Steril; 2012 Oct; 98(4):881-7.e1-2. PubMed ID: 22819187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study.
    Demirol A; Gurgan T
    Fertil Steril; 2009 Aug; 92(2):481-5. PubMed ID: 18990368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
    Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of in vitro fertilization versus intracytoplasmic sperm injection in extremely low oocyte retrieval cycles.
    Ou YC; Lan KC; Huang FJ; Kung FT; Lan TH; Chang SY
    Fertil Steril; 2010 Jan; 93(1):96-100. PubMed ID: 19108823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IVF versus ICSI for the fertilization of in-vitro matured human oocytes.
    Walls M; Junk S; Ryan JP; Hart R
    Reprod Biomed Online; 2012 Dec; 25(6):603-7. PubMed ID: 23063820
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical application of in vitro maturation of human immature oocytes for infertile women with polycystic ovary syndrome].
    Xu YP; Xiang HF; Zou WW; Li ZL; Zhang ZG; Zhou P; Cao YX
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):14-8. PubMed ID: 22455687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
    Morgia F; Sbracia M; Schimberni M; Giallonardo A; Piscitelli C; Giannini P; Aragona C
    Fertil Steril; 2004 Jun; 81(6):1542-7. PubMed ID: 15193474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
    Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
    Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.
    Polyzos NP; Tournaye H; Guzman L; Camus M; Nelson SM
    Fertil Steril; 2013 Aug; 100(2):430-7. PubMed ID: 23668992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fertilization and embryo development with spermatozoa obtained from testicular sperm extraction into oocytes generated from human chorionic gonadotropin-primed in vitro maturation cycles.
    Son WY; Chung JT; Henderson S; Reinblatt S; Buckett W; Chan PT; Holzer H
    Fertil Steril; 2013 Oct; 100(4):989-93. PubMed ID: 23806848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obesity and Clomiphene Challenge Test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection.
    van Swieten EC; van der Leeuw-Harmsen L; Badings EA; van der Linden PJ
    Gynecol Obstet Invest; 2005; 59(4):220-4. PubMed ID: 15753618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
    Huber M; Hadziosmanovic N; Berglund L; Holte J
    Fertil Steril; 2013 Nov; 100(5):1270-6. PubMed ID: 23931964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endometrial thickness is related to miscarriage rate, but not to the estradiol concentration, in cycles down-regulated with gonadotropin-releasing hormone antagonist.
    Detti L; Yelian FD; Kruger ML; Diamond MP; Rode A; Mitwally MF; Puscheck EE
    Fertil Steril; 2008 Apr; 89(4):998-1001. PubMed ID: 17678904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro fertilization outcomes in treated hypothyroidism.
    Busnelli A; Somigliana E; Benaglia L; Leonardi M; Ragni G; Fedele L
    Thyroid; 2013 Oct; 23(10):1319-25. PubMed ID: 23544891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.